Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-110.34%EBIT Margin
VS
Market
Sector
Industry
History
$ 2.21Close
$ 0.56 - $ 3.04 52-Week Range
Ticker Information
Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSPERO THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRO - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -53.6M | -110.34% | $ 48.58M |
| 3/31/2025 | $ -69.76M | -156.48% | $ 44.58M |
| 12/31/2024 | $ -68.57M | -142.91% | $ 47.98M |
| 9/30/2024 | $ 3.61M | 3.39% | $ 106.45M |
| 6/30/2024 | $ 20.05M | 16.93% | $ 118.46M |
| 3/31/2024 | $ 26M | 23.43% | $ 110.98M |
| 12/31/2023 | $ 25.4M | 24.48% | $ 103.78M |
| 9/30/2023 | $ 597K | 0.77% | $ 77.7M |
| 6/30/2023 | $ -10.08M | -18.59% | $ 54.23M |
| 3/31/2023 | $ -26.73M | -49.96% | $ 53.51M |
Key Performance Insights, Last 5 Years
- SPERO THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -766.14%.
- Over the past 5 years, SPERO THERAPEUTICS INC's average EBIT % has been -345.6%.
- The median EBIT % for SPERO THERAPEUTICS INC during this period was -149.69%
- SPERO THERAPEUTICS INC reached its highest EBIT % over the past 5 years at 24.48%.
- The lowest EBIT % recorded by SPERO THERAPEUTICS INC in the same timeframe -1110.77%
SPERO THERAPEUTICS INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for SPERO THERAPEUTICS INC is calculated as follows: EBIT [ $ -84.68M ] / Revenues [ $ 11.05M ]
(=) EBIT % [ -766.14% ] SPRO - EBIT Margin, Last 5 years
-1110.77%
Minimum
Sep 30, 2022
24.48%
Maximum
Dec 31, 2023
-345.6%
Average
-149.69%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |